Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Immune Checkpoint Receptors in AML-Leukemic Initiating Cells
ClinicalTrials.gov study NCT03449745. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06068868. IPD Sharing: NO. Countries: 5. Publications: 0.
CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）
ClinicalTrials.gov study NCT03556982. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Clinical Study of VA-CAG as Induction Therapy in Newly Diagnosed AML Patients
ClinicalTrials.gov study NCT05662956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells
ClinicalTrials.gov study NCT04169022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS
ClinicalTrials.gov study NCT01423175. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML
ClinicalTrials.gov study NCT01274195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML
ClinicalTrials.gov study NCT04061239. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
ClinicalTrials.gov study NCT05133882. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML
ClinicalTrials.gov study NCT06741722. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01451268. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML
ClinicalTrials.gov study NCT02229266. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE
ClinicalTrials.gov study NCT05193448. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
ClinicalTrials.gov study NCT05233618. IPD Sharing: NO. Countries: 1. Publications: 0.
Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)
ClinicalTrials.gov study NCT05749276. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05241106. IPD Sharing: NO. Countries: 1. Publications: 0.
Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML
ClinicalTrials.gov study NCT05654194. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants
ClinicalTrials.gov study NCT05367401. IPD Sharing: YES. Countries: 0. Publications: 0.
Healthcare Resource Utilization in Adults Diagnosed With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05488613. IPD Sharing: NO. Countries: 1. Publications: 0.
Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)
ClinicalTrials.gov study NCT01301820. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.